<DOC>
	<DOCNO>NCT00704223</DOCNO>
	<brief_summary>This study conduct Europe . The aim observational study evaluate incidence adverse event use NovoMix® 70 normal clinical practice condition Austria .</brief_summary>
	<brief_title>Observational Study Evaluate Safety Efficacy NovoMix® 70 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Type 2 diabetes HbA1c 7 % No contraindication NovoMix® 70 Type 1 diabetes Subjects participate clinical trial another observational study Subjects previous basisbolus insulin therapy Women pregnant , breast feeding woman child bear capacity use reliable contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>